-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
-
Summary
-
Soleno Therapeutics Inc quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from Q2 2014 to Q3 2024.
- Soleno Therapeutics Inc Weighted Average Number of Shares Outstanding, Diluted for the quarter ending September 30, 2024 was 41.9M shares, a 266% increase year-over-year.
- Soleno Therapeutics Inc annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 16.5M shares, a 96.4% increase from 2022.
- Soleno Therapeutics Inc annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 8.4M shares, a 57.9% increase from 2021.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)